GLP-1RA therapy enhances microbial diversity and stability, thereby facilitating enduring metabolic enhancements beyond mere receptor activation (Gofron et al
A Promising Treatment Option Tirzepatide has emerged as a promising treatment for HFpEF in people with obesity, a group historically underserved by effective therapies
ODT formulations may have different side effect profiles since they bypass the stomach, but without clinical data, this remains theoretical
Your body does not naturally produce B12, which can lead some individuals to become deficient, and in some cases, anemic
Despite strong growth, InvestingPro analysis indicates the stock is trading at a high EBITDA valuation multiple, suggesting investors are pricing in continued successful execution of the companys capacity expansion plans and customer conversion strategy